Back

Risk score distribution and one-year MACE prediction by CAD-OLT and CAD-LT in liver transplant candidates

31 August 2026 (12:15 - 12:45)
Organised by: Logo
Congress Presentation Part of: Ageing, frailty, and multimorbidity in cardiovascular disease Noncardiac Surgery / Presurgical Assessment ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Carlos Huerta

Methodist Health System, Dallas (United States of America)

4 More presentations in this session

Presentation thumbnail
Long-term subclinical cardiac damage in people living with human inmunodeficiency virus.
Doctor J. Gomez Diego (Fuenlabrada, ES)
Abstract
Presentation thumbnail
A serum-marker-based framework for inferring CD4+T-cell lineage shifts: introducing the tpi model in atherosclerosis
Doctor C. Lu (Shijiazhuang, CN)
Abstract
Presentation thumbnail
Accelerating access to specialist cardiac amyloidosis care in an elderly population: an nhs–industry collaborative working model
Professor J. Gillmore (Greater London, GB)
Abstract
Presentation thumbnail
Infective endocarditis in the elderly: a comparative cohort study of patients aged ≥75 years
Doctor A. Fonseca Vazao (Leiria, PT)
Abstract

Access the full session

Session thumbnail
Ageing, frailty, and multimorbidity in cardiovascular disease

The Event

Event poster

ESC Congress 2026

31 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Visual coronary artery calcium assessment on routine chest CT can readily and cheaply identify liver transplant recipients with a low cardiac risk
1 September 2024
thumbnail
Congress Presentation
Derivation and validation of a novel prognostic model for patients with light chain (AL) cardiac amyloidosis
29 June 2021
thumbnail
Congress Presentation
Risk stratification in unprotected left main coronary disease: do we have the tools?
28 August 2020
thumbnail
Congress Presentation
Liver steatosis, metabolically healthy obesity and ten-year cardiovascular disease risk: results from a population based cohort study.
28 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources